Optimizing Early Detection of Diabetic Kidney Disease through Synergistic Biomarkers and Serum Metabolites in Human

Puntos clave

• Enhanced early detection of diabetic kidney disease occurs with the integration of synergistic biomarkers and serum metabolites, leading to better outcomes.
• The combined approach of using both biomarkers and serum metabolites shows significant potential for impacting disease progression.
• Assessment through integration of various biomarkers indicates a more reliable identification of diabetic kidney disease at earlier stages.
• This strategy supports the need for more comprehensive screening methods to identify diabetic kidney disease effectively.